0001209191-17-037112.txt : 20170602
0001209191-17-037112.hdr.sgml : 20170602
20170602151416
ACCESSION NUMBER: 0001209191-17-037112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170601
FILED AS OF DATE: 20170602
DATE AS OF CHANGE: 20170602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vishnoi Rohit
CENTRAL INDEX KEY: 0001706245
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 17887583
MAIL ADDRESS:
STREET 1: 1333 SOUTH SPECTRUM BLVD, SUITE 100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-01
0
0001516479
Insys Therapeutics, Inc.
INSY
0001706245
Vishnoi Rohit
1333 SOUTH SPECTRUM BLVD, SUITE 100
CHANDLER
AZ
85286
1
0
0
0
Common Stock
2017-06-01
4
P
0
4000
14.1438
A
4000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.14 to $14.145, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ Darryl Baker, Attorney-in-fact
2017-06-02